Episode notes
Friday, September 25, 2026 In today's episode, Dr. Will Flanary (@drglaucomflecken) & Adam Rose (@Adjoro) cover new research on colonoscopy surveillance after high risk adenomas. A large randomized trial found that waiting five years instead of three led to nearly identical colorectal cancer rates. They explain what the interim results mean for screening guidance and what remains unanswered. Then they turn to a Washington court ruling on whether raw audio from an AI scribe counts as part of the medical record. Plus: they discuss Nathan Fielder’s documentary on Theranos founder Elizabeth…
Podcast
Medlines
Human Content, Inc. · Health · English
Healthcare is changing at breakneck speed, and let's face it, staying informed is getting harder by the day. If only there were a way to get the industry news you need in less time than it takes to get prior auth approved. (Spoiler: There is.) Every Friday, start your day with Dr. Will Flanary (aka
More from Medlines All episodes →
-
E15 · 9 Oct 2026 · 12 min
GLP-1 Shakeups and Airline Emergency Kit Upgrades
Friday, October 9, 2026 In today's episode, Dr. Will Flanary (@drglaucomflecken) & Adam Rose (@adjoro) cover Phase 3 results for retatrutide with up to 28.3% average weight loss at 80 weeks. They explain dosing, tolerability and what remains unproven for heart and kidney outcomes and how retatrutide compares with current GLP-1 options. They also break down a federal proposal to modernize airline emergency kits around nine life threatening categories with airline level discretion. Plus: they discuss a growing pediatric heart valve, the return of Doc, Best Medicine, Chicago Med and Grey’s…
-
E14 · 2 Oct 2026 · 13 min
The Future of Cancer Screening and... Horse Therapy?
Friday, October 2, 2026 In today's episode, Dr. Jennifer Lincoln (@drjenniferlincoln) joins Medlines as a new anchor! She and Eva Johnson cover an FDA advisory panel vote on an early cancer detection blood test for adults 50 and older. The panel called the test safe, then split on whether it works. The agency still has to rule. They also walk through a UCSF comparison of myomectomy and radiofrequency ablation for uterine fibroids. Both treatments improved symptoms over two years, and neither difference reached the study threshold for a clinically important advantage. Plus: new findings on…
-
E12 · 18 Sep 2026 · 14 min
The Pitt's Big Night and Modernizing Migraine Relief
Friday, September 18, 2026 In today's episode, Dr. Alok Patel (@AlokPatelMD) & Eva Johnson cover new migraine prevention guidelines that put CGRP targeted therapies up front as first line options without requiring older drugs first. They explain who qualifies at four or more headache days per month, how to assess response after 8 to 12 weeks, and safety notes for pregnancy. They also break down The Pitt's second Emmy run, with 25 nominations and back to back wins for Noah Wyle and Outstanding Drama. Plus: rising rabies exposures, an MRSA outbreak tied to bouncy castles, and more. Coverage…
-
E11 · 11 Sep 2026 · 15 min
Pig Kidney Transplants and ER Violence Concerns
Friday, September 11, 2026 In today's episode, Dr. Alok Patel (@AlokPatelMD) & Adam Rose (@Adjoro) cover a record pig kidney bridge that kept a New Hampshire man off dialysis for 271 days with no sign of rejection and without blocking his next human transplant. They break down the 69 edits behind the eGenesis organ and why The Lancet case matters for over 100,000 Americans waiting for a kidney. They also dig into new UK and US surveys showing most emergency staff face violence and what leaders say must change. Plus: a sharp rise in GLP-1 prescriptions for young children, fake weight loss…
-
E10 · 4 Sep 2026 · 13 min
Robots Can Draw Your Blood and Rethinking Statins After 70
Friday, September 4, 2026 In today's episode, Dr. Will Flanary (@drglaucomflecken) & Eva Johnson cover the FDA authorization of Aletta, the first standalone robot that draws blood without hands on operator intervention. The Vitestro system uses near infrared light and Doppler ultrasound to find veins, and one phlebotomist can supervise three units at a 94.5 percent first stick rate. They also break down a trial of atorvastatin in nearly 10,000 healthy adults over 70, where a 30 percent relative reduction in cardiovascular events came with no significant gain in disability free survival.…
-
E9 · 28 Aug 2026 · 13 min
Prior Auth Gets Adrenalized and Dangerous Trials in China
Friday, August 28, 2026 In today's episode, Alok Patel (@AlokPatelMD) & Adam Rose (@Adjoro) cover Epic bringing prior authorization checks directly into the EHR. New federal rules will require Medicare Advantage Medicaid and ACA marketplace insurers to support electronic prior authorization APIs by January 1. Epic's Coverage Requirements Discovery shows coverage requirements and documentation needs inside the chart without payer portals or phone calls. They also break down undisclosed deaths in Chinese gene editing trials involving high dose AAV9 vectors and what the delays reveal about…
-
E8 · 21 Aug 2026 · 13 min
Milestone Prescription Price Drops and the CTE Diagnostic Puzzle
Friday, August 21, 2026 In today's episode, Dr. Will Flanary (@drglaucomflecken) & Eva Johnson cover a historic drop in prescription drug prices. Prices fell 3.1% over the past year, the steepest annual decline since 1963, and the anchors unpack what is actually driving it from generics to GLP-1 competition to the Inflation Reduction Act. They also break down why the national index does not always match what patients pay at the pharmacy counter. Plus: a split between two studies on whether CTE can be diagnosed in living patients, and more. Coverage Timeline: (00:00) Intro (01:04) Drug Prices…
Take it with you
The Melo app keeps playing with the screen off, works in the car and on your watch, wakes you to your station, and browses the whole catalogue offline. Free, no ads, no account.
